ProCE Banner Activity

Positioning 2-Drug ART in Two Key Treatment Settings

Conference Coverage
Clinical Thought
With longer-term data now available, our understanding of the use for 2-drug regimens in first-line and maintenance ART settings has expanded. Here’s my take on how that affects practice.

Released: February 24, 2020

Expiration: February 22, 2021

No longer available for credit.

Share

Faculty

Alexandra Calmy

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Alexandra Calmy, MD, FMH, PhD

HIV/AIDS Unit Director
Infectious Diseases Division
Geneva University Hospitals
University of Geneva
Geneva, Switzerland

Alexandra Calmy, MD, FMH, PhD, has disclosed that she has received fees for non-CME/CE services from Gilead Sciences.